Effect of soy oil containing stearidonic acid on growth performance and fillet fatty acid composition of Atlantic salmon

The effects of stearidonic acid (SDA; 18:4n‐3) derived from SDA‐enhanced, genetically modified soybeans (Monsanto Company, St Louis, MO, USA) on growth performance and fatty acid (FA) composition of large Atlantic salmon (Salmo salar; 2.1 kg initial weight) were evaluated. There was a stepwise decrease in feed intake and subsequent weight gain of immature Atlantic salmon with increased replacement of fish oil by SDA soy oil from 0%, 50% to 100% added oil. SDA increased and n‐3 highly unsaturated FA (n‐3 HUFA; eicosapentaenoic acid + docosahexaenoic acid) decreased in the diet and corresponding fillet with increased SDA oil inclusion. Salmon with the same weight gain fed SDA oil compared with rapeseed oil at 50% fish oil replacement had similar n‐3 HUFA fillet levels indicating little or no increased synthesis of n‐3 HUFA from SDA for deposition in the fillet. However, elongation of dietary SDA to 20:4n‐3 for deposition in the fillet of SDA oil fed fish was indicated. The increased SDA and 20:4n‐3 in the fillet of Atlantic salmon fed SDA oil compared with rapeseed oil at 50% fish oil replacement may be more effective as precursors for EPA in humans than 18:3n‐3 which was in the fillet at similar levels.